Medicaid expansion is a key provision by which the Affordable Care Act seeks to improve access to health insurance. However, there is concern over the quality and cost of care received by Medicaid beneficiaries. We previously demonstrated that payer status predicts index care setting, which influences rates of 30-day revisits following definitive surgery for urinary stone disease. In this context, we used all-payer claims data to identify predictors of 30-day revisit and associated cost following definitive surgery for nephroureterolithiasis.
INTRODUCTION AND OBJECTIVES:
Medicaid expansion is a key provision by which the Affordable Care Act seeks to improve access to health insurance. However, there is concern over the quality and cost of care received by Medicaid beneficiaries. We previously demonstrated that payer status predicts index care setting, which influences rates of 30-day revisits following definitive surgery for urinary stone disease. In this context, we used all-payer claims data to identify predictors of 30-day revisit and associated cost following definitive surgery for nephroureterolithiasis.
METHODS: All-payer data from the 2014 Healthcare Cost and Utilization Project State Databases from Florida and New York were used to identify all index elective definitive surgical interventions for nephroureterolithiasis in the form of ureteroscopy (URS) or shockwave lithotripsy (SWL). Patient demographics, regional data, 30-day revisit rates, and total charges (converted to costs) associated with revisits were determined. Multivariate logistic regression adjusted for facility clustering was utilized to identify predictors of re-intervention following definitive therapy for nephroureterolithiasis.
RESULTS: Of the 27,527 unique patients undergoing either an elective index URS (n[16, 572) CONCLUSIONS: We demonstrated that payer status and index care setting are independent predictors of 30-day revisit following elective definitive stone therapy, with Medicaid beneficiaries experiencing higher 30-day revisit rates. Our findings have important policy and cost implications in the setting of recent efforts to expand healthcare coverage through Medicaid expansion. The present study was aimed to evaluate the surgical outcomes at 17 years after the Tensionfree Vaginal Tape (TVT) surgery which was performed to manage females with stress urinary incontinence (SUI).
METHODS: Among 110 women with SUI who underwent the TVT procedure between March 1999 and December 2000, 51 patients were followed up for at least 17 years postoperatively. Preoperative evaluation of the patients was performed with history taking, physical examinations, one-hour pad tests, urine analysis, urine cultures and complete multichannel urodynamic studies. Long-term evaluations were performed via questionnaires on the durability of the surgical outcome and the patients' satisfaction with the procedure. All the patients were asked about their voiding symptoms as well as any recurrence by conducting detailed telephone interviews.
RESULTS: The mean follow-up period was 207.62 AE 8.46 months. Of the 51 patients who were followed up for at least 17 years, the patients were classified according to their symptom grades; grade I (n [13, 25.49%), grade II (n[28, 54.90%) and grade III (n[10, 19.61%) . The TVT procedure remained successful in 42 patients (82.35%): SUI was remained cured in 28 patients (54.90%) and improved in 14 patients (27.45%) while recurred incontinence was observed in 9 patients (17.65%). According to the telephone interviews, 26 patients (50.98%) were very satisfied and 16 patients (31.37%) were satisfied with the TVT procedure. However, 6 (11.76%) and 3 (5.88%) patients answered 'tolerable' and 'dissatisfied', respectively, and all of these patients had recurred SUI. Among the investigated patients, no serious or long-term complications related to the procedure were observed.
CONCLUSIONS: The TVT surgery is an effective treatment for stress urinary incontinence, with long-term durability of continence and minimal complications related to the surgery. Vol. 201, No. 4S, Supplement, Friday, May 3, 2019 THE JOURNAL OF UROLOGY Ò e61
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